Answers are grounded in this paper and cite their sources.
Introduction: Congenital sideroblastic anemia is a heterogeneous disorder characterized by ineffective erythropoiesis and microcytic hypochromic anemia. The phenotypic expression of CSA is variable and the most common form is X-linked, caused by mutations of delta- aminolevulinic acid synthase 2 (ALAS2).We report a novel missense mutation in the ALAS2 gene in a young Indian male patient. Case details: A 19 year old gentleman presented with severe anemia. Bone marrow revealed ringed sideroblasts and clinical exome sequencing revealed a novel mutation (p.Arg204Leu) of ALAS2 gene. Discussion: More than 100 pathogenic variants in ALAS2 gene have been reported till date. In our case, one novel missense pathogenic variant was identified in Exon 5 which resulted in the amino acid substitution of Leucine for Arginine at codon 204, which responded well to pyridoxine. Conclusion : Our case adds to the XLSA pathogenic variant database and expands the number of cases of the rare disease.
No takes yet. Share an insight, caveat, or question.
Machiraju et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: